메뉴 건너뛰기




Volumn 54, Issue 68, 1998, Pages

Evaluation of the losartan in hemodialysis (ELHE) study

Author keywords

Anaphylactoid reaction; Dialysis membranes; Hemodialysis; High blood pressure; Losartan

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; POLYSULFONE; ACRYLIC ACID RESIN; ACRYLONITRILE; AN 69; AN-69; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE;

EID: 0031741192     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.06825.x     Document Type: Article
Times cited : (49)

References (12)
  • 1
    • 0028953102 scopus 로고
    • Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
    • J.D. Harnett R.N. Foley G.M. Kent P.E. Barre D. Murray P.S. Parfrey Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors Kidney Int 47 1995 884 890
    • (1995) Kidney Int , vol.47 , pp. 884-890
    • Harnett, J.D.1    Foley, R.N.2    Kent, G.M.3    Barre, P.E.4    Murray, D.5    Parfrey, P.S.6
  • 2
    • 0029154076 scopus 로고
    • Hypertension in the hemodialysis population: A survey of 649 patients
    • M.M. Salem Hypertension in the hemodialysis population: A survey of 649 patients Am J Kidney Dis 26 1995 461 468
    • (1995) Am J Kidney Dis , vol.26 , pp. 461-468
    • Salem, M.M.1
  • 3
    • 0025221601 scopus 로고
    • Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis
    • L. Verresen M. Waer Y. Vanrenterghem P. Michielsen Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis Lancet 336 1990 1360 1362
    • (1990) Lancet , vol.336 , pp. 1360-1362
    • Verresen, L.1    Waer, M.2    Vanrenterghem, Y.3    Michielsen, P.4
  • 4
    • 0026422805 scopus 로고
    • Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis
    • M. Jadoul Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis Lancet 337 1991 112 113
    • (1991) Lancet , vol.337 , pp. 112-113
    • Jadoul, M.1
  • 5
    • 0026041711 scopus 로고
    • Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer
    • E.L. Parnes W.B. Shapiro Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer Kidney Int 40 1991 1148 1152
    • (1991) Kidney Int , vol.40 , pp. 1148-1152
    • Parnes, E.L.1    Shapiro, W.B.2
  • 6
    • 0029953214 scopus 로고    scopus 로고
    • Risk factors for acute hypersensitivity reactions in hemodialysis
    • P. Simon J. Potier H.E. Thebaud Risk factors for acute hypersensitivity reactions in hemodialysis Nephrologie 17 1996 163 170
    • (1996) Nephrologie , vol.17 , pp. 163-170
    • Simon, P.1    Potier, J.2    Thebaud, H.E.3
  • 8
    • 0028958943 scopus 로고
    • Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release
    • D.H. Krieter E. Fink G. Bonner H.M. You T. Eisenhauer Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release Nephrol Dial Transplant 10 1995 509 513
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 509-513
    • Krieter, D.H.1    Fink, E.2    Bonner, G.3    You, H.M.4    Eisenhauer, T.5
  • 9
    • 0028347607 scopus 로고
    • Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes
    • L. Verresen E. Fink H.D. Lemke Y. Vanrenterghem Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes Kidney Int 45 1994 1497 1503
    • (1994) Kidney Int , vol.45 , pp. 1497-1503
    • Verresen, L.1    Fink, E.2    Lemke, H.D.3    Vanrenterghem, Y.4
  • 10
    • 0028935595 scopus 로고
    • Safety and torelability of losartan potassium an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
    • A.I. Goldberg M.C. Dunlay C.S. Sweet Safety and torelability of losartan potassium an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension Am J Cardiol 75 1995 793 795
    • (1995) Am J Cardiol , vol.75 , pp. 793-795
    • Goldberg, A.I.1    Dunlay, M.C.2    Sweet, C.S.3
  • 11
    • 0030798211 scopus 로고    scopus 로고
    • Clinical safety and tolerability of losartan
    • M. Weber Clinical safety and tolerability of losartan Clin Ther 19 1997 604 616
    • (1997) Clin Ther , vol.19 , pp. 604-616
    • Weber, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.